Wolverine Trading
NVAX icon

Wolverine Trading’s Novavax NVAX Stock Holding History

Wolverine Trading’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,208
Closed -$169K – 5318
2025
Q1 		$169K Buy
24,208
+13,268
+121% +$110K ﹤0.01% 4032
2024
Q4 		$86.8K Sell
10,940
-34,823
-76% -$336K ﹤0.01% 4841
2024
Q3 		$609K Sell
45,763
-39,231
-46% -$507K ﹤0.01% 2864
2024
Q2 		$1.08M Buy
+84,994
New +$855K ﹤0.01% 2134
2022
Q3 		– Sell
-25,302
Closed -$1.31M – 5101
2022
Q2 		$1.31M Sell
25,302
-11,501
-31% -$596K ﹤0.01% 1700
2022
Q1 		$2.75M Buy
36,803
+7,272
+25% +$648K ﹤0.01% 1494
2021
Q4 		$4.57M Sell
29,531
-5,740
-16% -$986K 0.01% 1208
2021
Q3 		$7.18M Sell
35,271
-6,025
-15% -$1.33M 0.01% 1034
2021
Q2 		$8.63M Buy
41,296
+12,590
+44% +$2.31M 0.01% 772
2021
Q1 		$4.97M Sell
28,706
-3,208
-10% -$639K 0.01% 1116
2020
Q4 		$3.8M Buy
31,914
+8,402
+36% +$893K 0.01% 1265
2020
Q3 		$2.54M Buy
23,512
+6,539
+39% +$797K 0.01% 1297
2020
Q2 		$1.42M Sell
16,973
-3,885
-19% -$149K ﹤0.01% 1682
2020
Q1 		$298K Buy
+20,858
New +$176K ﹤0.01% 3223
2019
Q1 		– Sell
-3,190
Closed -$117K – 5053
2018
Q4 		$117K Buy
3,190
+1,805
+130% +$70K ﹤0.01% 3930
2018
Q3 		$52K Buy
1,385
+616
+80% +$17.3K ﹤0.01% 4698
2018
Q2 		$32K Hold
769
– – ﹤0.01% 4983
2018
Q1 		$32K Buy
+769
New +$30.9K ﹤0.01% 4983
2017
Q4 		– Sell
-2,150
Closed -$52.5K – 5304
2017
Q3 		$49K Sell
2,150
-60
-3% -$1.34K ﹤0.01% 4232
2017
Q2 		$51K Buy
2,210
+304
+16% +$5.96K ﹤0.01% 4057
2017
Q1 		$48K Sell
1,906
-249
-12% -$6.85K ﹤0.01% 4007
2016
Q4 		$54K Sell
2,155
-6,711
-76% -$196K ﹤0.01% 4198
2016
Q3 		$365K Buy
8,866
+6,519
+278% +$842K ﹤0.01% 2968
2016
Q2 		$337K Buy
+2,347
New +$269K ﹤0.01% 2662

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wolverine Trading's NVAX Position: Q2 2025 in Review

Wolverine Trading sold out of Novavax (NVAX) in Q2 2025, closing a stake of 24,208 shares — an estimated $169K sold.

Wolverine Trading first reported a position in NVAX in Q2 2016 and held it in 24 quarters. The position peaked at $8.63M in Q2 2021. 250 funds tracked by Wall St. Rank hold NVAX as of Q2 2025.

  • Wolverine Trading reported no remaining Novavax position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 24,208 Novavax shares in Q2 2025, an estimated $169K.
  • Wolverine Trading first reported a position in Novavax in Q2 2016 and held it in 24 quarters.
  • Wolverine Trading's Novavax position peaked at $8.63M in Q2 2021.
  • 250 funds tracked by Wall St. Rank held Novavax as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.